You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Specific Protein Overexpression in Adult Non-Small Cell Lung

Not yet recruiting
  • Non Small Cell Lung Cancer
    • (no location specified)
    Sep 29, 2023

    NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Nintedanib, gefitinib, erlotinib, afatinib
    • (no location specified)
    Oct 2, 2023

    Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

    Not yet recruiting
    • Stage II-IIIB(N2) Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 26, 2023

    NSCLC Trial in Shanghai

    Not yet recruiting
    • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 20, 2023

      NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

      Recruiting
      • Non-small Cell Lung Cancer
      • +3 more
      • Yangzhou, Jiangsu, China
        People's hospital of northern jiangsu
      Sep 26, 2023

      NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Tirelizumab；Chemotherapy monotherapy
      • (no location specified)
      Jul 27, 2023

      NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Iowa City, Iowa
        University of Iowa
      Oct 10, 2023

      Identify Resected Non-small-cell Lung Cancer With High Risk of

      Recruiting
      • Non-small Cell Lung Cancer Stage IIIA
      • Resected non small cell lung cancer
      • Toulouse, France
        Julien MAZIERES
      Feb 8, 2023

      NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

      Not yet recruiting
      • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
      • (no location specified)
      Aug 27, 2023

      Non Small Cell Lung Cancer Metastatic Trial (MRI)

      Not yet recruiting
      • Non Small Cell Lung Cancer Metastatic
      • MRI
      • (no location specified)
      May 16, 2023

      Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      Aug 8, 2023

      NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • (no location specified)
      Sep 6, 2023

      NSCLC Trial in Omaha (PLB1004)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Omaha, Nebraska
        Nebraska Cancer Specialists
      Sep 19, 2023

      Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

      Recruiting
      • Untreated Advanced Non-small Cell Lung Cancer
      • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
      • Fuzhou, Fujian, China
        Fujian Cancer Hospital
      Nov 13, 2023

      Examination of Trends in Non-Small Cell Lung Cancer Patients'

      Not yet recruiting
      • Non-Small Cell Lung Cancer
        • (no location specified)
        Mar 10, 2023

        NSCLC Trial in Guangzhou (BL-M07D1)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Nov 1, 2023

        NSCLC Trial in Houston (Amivantamab, Tepotinib)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Houston, Texas
          MD Anderson Cancer Center
        Oct 9, 2023

        Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

        Recruiting
        • Non Small Cell Lung Cancer
        • +2 more
        • Port Saint Lucie, Florida
        • +1 more
        Aug 11, 2023

        NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

        Not yet recruiting
        • NSCLC
        • Non-small Cell Lung Cancer
        • Apatinib + Fluzoparib
        • Apatinib + Fluzoparib + Adebrelimab
        • Guangzhou, Guangdong, China
          Sun Yat-Sen University Cancer Center
        Jun 27, 2023

        NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Tislelizumab IV
        • +2 more
        • (no location specified)
        Oct 25, 2023

        NSCLC Trial in Beijing

        Recruiting
        • NSCLC
          • Beijing, China
            Yuyan Wang
          Oct 10, 2023

          Integrative Multi-Omics Testing for Immunotherapy Response in

          Recruiting
          • Lung Cancer
            • Guangzhou, Guangdong, China
              Nanfang hospital
            Jun 29, 2023

            Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, AK104, caboplatin)

            Not yet recruiting
            • Advanced Non-small-cell Lung Cancer
            • Shanghai, China
              Shanghai Pulmonary Hospital
            Jun 6, 2023

            NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

            Not yet recruiting
            • Non-Small Cell Lung Cancer
            • +2 more
            • Fairfax, Virginia
              NEXT Virginia
            Sep 18, 2023